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Abstract
Arterial spin labeling (ASL) is a cardiovascular magnetic resonance (CMR) technique for mapping regional
myocardial blood flow. It does not require any contrast agents, is compatible with stress testing, and can be
performed repeatedly or even continuously. ASL-CMR has been performed with great success in small-animals,
but sensitivity to date has been poor in large animals and humans and remains an active area of research.
This review paper summarizes the development of ASL-CMR techniques, current state-of-the-art imaging methods, the
latest findings from pre-clinical and clinical studies, and future directions. We also explain how successful developments
in brain ASL and small-animal ASL-CMR have helped to inform developments in large animal and human ASL-CMR.
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Background
Arterial spin labeling is a cardiovascular magnetic res-
onance (CMR) technique for quantifying tissue blood
flow, non-invasively and without contrast agents [1, 2].
Radiofrequency pulses are used to modify the longitudinal
magnetization of arterial blood, creating an endogenous
label (or tracer) that decays with the time-constant equal
to the T1 relaxation time, about 1.5 seconds for blood at 3
Tesla. After a delay to allow labeled blood to flow into the
target tissue, images are acquired that reflect inflow of la-
beled blood as well as static tissue whose magnetization
exchanges with that of the inflowing blood. A second set
of images is acquired in the absence of a preceding label-
ing pulse. The difference between these two image sets re-
flects the amount of labeled blood that has been delivered
to the imaging region, and with appropriate labeling, im-
aging, and perfusion model, can be made directly propor-
tional to tissue blood flow (in mL-blood per g-tissue per
minute). This process is illustrated in Fig. 1.
For myocardial perfusion applications, ASL is an at-
tractive alternative to first-pass CMR and traditional
nuclear medicine for two reasons. First, it does not
require intravenous contrast agents or ionizing radio-
nuclides, and therefore can be performed repeatedly
or even continuously with no incremental risk to the pa-
tient. Second, it provides measurements that are directly
proportional to myocardial blood flow as opposed to a
relative measurement that requires designating an area of
normal myocardium for comparison [3, 4]. Therefore,
ASL could be more sensitive for detection of disease that
reduces perfusion globally such as balanced ischemia,
microvascular disease and multi-vessel disease.
Review
First-pass gadolinium enhanced perfusion CMR has a
long history in both clinical research and diagnostic
routine, mainly for the evaluation of ischemic heart
disease [5]. Its superiority for diagnosing CAD com-
pared with SPECT was shown in several large multi-
center trials including CE-MARC and MR-IMPACT
[6–8]. First-pass CMR owes its success mainly to its
high spatial resolution compared with nuclear imaging
techniques. Also, the contrast change produced by
the contrast agent bolus during a perfusion measure-
ment is high (of the order of 60 % with saturation-
recovery SSFP techniques in normal myocardium [9]),
the delineation of territories with perfusion defects
can be done without sophisticated post-processing
tools. The standard approach for clinical interpret-
ation is visual delineation of hypo-perfused territories.
Quantitative or at least a semi-quantitative analysis of
perfusion is desirable particularly in non-ischemic car-
diomyopathies affecting microvasculature, which cause
only subtle and non-focal defects. While first-pass CMR
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does allow quantification of blood flow, the mathem-
atical modeling of contrast dynamics is relatively
complex and hasn’t yet found consensus in the com-
munity. Absolute quantification with first-pass CMR
requires a measurement of the Arterial Input Function
(AIF), which has to be obtained without saturation of the
contrast/concentration curve. This implies the use of
either dual-contrast pulse sequences [10] or dual-bolus
protocols [11, 12]. First-pass CMR is therefore an excel-
lent and widely recognized method for identifying and de-
lineating altered tissue in ischemic heart disease thanks to
very good detection sensitivity. Robust absolute MBF
quantification approaches are, however, still subject of on-
going research.
One important limitation of first-pass CMR stems
from the use of Gadolinium-based contrast agents
(GBCA), which have known toxicity in patients with
renal failure. In these patients, excessive use can lead to
organ fibrosis and failure. GBCA’s are contraindicated in
patients with end-stage renal disease (ESRD), which is a
small but significant part of the CMR patient population,
due to their need for frequent cardiovascular assessment.
ESRD prevalence is on the rise, with an annual growth
rate of 3–4 % in the US [13], and ~7 % worldwide [14].
These patients would benefit from a new safer alterna-
tive, as they require ischemic heart disease testing every
12 months to a) determine preoperative cardiovascular
risk prior to kidney transplant surgery and b) because
they have >10 times higher cardiovascular mortality than
the general population [15, 16]. These patients cannot
receive GBCA because of poor kidney function and ex-
perience an unreasonably large radiation dose from fre-
quent stress testing using SPECT or PET [17–19].
Today, many centers use a less sensitive dobutamine
stress echo test to screen for cardiovascular disease in
ESRD patients.
ASL-CMR is a totally non-invasive alternative that
uses magnetically labeled blood as an endogenous tracer.
It would therefore offer accessibility of perfusion CMR
to patients with contraindications to GBCA. ASL-CMR
is therefore increasingly relevant in patients with
Chronic Kidney Disease (CKD), the elderly in general,
and the growing number of patients who simply refuse
diagnostic tests involving contrast or radiation.
The contrast differences created by magnetic labeling
of blood are inherently limited, and ASL therefore
features much lower sensitivity than 1st pass techniques.
The signal in ASL is indeed directly proportional to
myocardial blood flow. The myocardial tissue mag-
netization difference created by magnetic blood labeling
depends on the labeling type and is lower than 4 % in
humans (as an example: 1.5 % [20]). However, for a
number of reasons, absolute quantification with ASL is
at least theoretically more reliable and more accurate: 1)
The created bolus of labeled magnetization is short and
its spatial profile is almost perfectly rectangular, 2) the
Fig. 1 ASL is a subtraction technique. Images are acquired (top) with and (bottom) without a preceding RF pulse that labels inflowing blood. The
difference between these two images can be made directly proportional to myocardial blood flow in units of mL-blood/g-tissue/min.
(Figure courtesy of Eric C. Wong, MD, PhD, University of California, San Diego)
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timing and shape of this bolus do not vary between ex-
periments, 3) the signal to concentration relation is per-
fectly linear, since only water is used as tracer, and 4) the
measurement is freely repeatable without bias across
consecutive measurements.
The repeatability of ASL-CMR is particularly interest-
ing for rest/stress comparisons, since measurements
could be carried out in a continuous way to monitor
tissue blood flow changes during stress. Furthermore,
the possibility to do absolute quantification would make
ASL a good candidate for longitudinal therapeutic moni-
toring and disease follow-up studies.
From the brain to the heart
ASL methods for measuring cerebral blood flow are
robust and widely used in the research setting, for ex-
ample, to assess stroke [21, 22], and functional brain
activation [23–25]. A recent consensus document has
provided recommended protocols that are available
on commercial platforms and has received broad sup-
port from the developer and user community [26].
The success and maturity of ASL in the brain has
provided significant motivation for ASL-CMR and has
provided a significant toolbox of techniques that may
be applied in ASL-CMR.
There are several important physiological and practical
factors that necessitate the use of different ASL labeling
and imaging methods for measuring myocardial blood
flow (MBF) and cerebral blood flow (CBF), respectively.
These are summarized in Table 1, and discussed briefly
here. Tissue blood flow is higher in the myocardium
compared to the brain, roughly 2x higher at rest and 5–7x
higher during vasodilation, resulting in a stronger ASL
signal. Water exchange kinetics of labeled spins to tissue
water are assumed to be instantaneous in the heart while
the blood-brain barrier (BBB) decreases the exchange rate
of water in the brain. The upstream pathway that blood
travels to perfuse the myocardium is complicated com-
pared to the brain. This influences scan timing, and the
selection of labeling geometries as blood that perfuses the
myocardium may have been in the imaging volume a few
seconds prior. The heart is also moving rapidly and blood
flow is highly pulsatile. This requires labeling and imaging
methods that are synchronized to the cardiac cycle. Im-
aging is typically performed during quiescent periods,
end-systole and mid-diastole. The intrinsic SNR efficiency
of modern MRI systems with the latest in receiver coil
technology is 3.5x lower in the heart compared to the
brain (for normal weight subjects). This is due largely to
the need for large coil arrays, with greater distance
Table 1 Factors that impact the use of ASL in heart and in the brain, for measuring myocardial blood flow (MBF) and cerebral
blood flow (CBF), respectively
Heart (MBF) Brain (CBF)
Tissue Blood Flow 0.5 – 1.5 mL/g/min (rest)
3.0 – 5.0 mL/g/min (stress)
0.35 – 0.55 mL/g/min [100]
Water Kinetics Instantaneous exchange Decreased water exchange due to blood
brain barrier (BBB)
Blood pathway Many directions; Blood passes through
left atrium, left ventricle, aortic root,
coronary arteries and then myocardium.
Unidirectional; Internal carotids and vertebral
arteries deliver blood to the Circle of Willis,
then to branch vessels, then to the brain.
Blood flowing primarily inferior to superior.
Motion Significant cardiac motion;
Quiescent periods are:
End systole: ~80 ms long
Mid diastole: 0-150 ms long depending
on heart rate.
Respiratory motion must be
handled either by limiting the
acquisition time to a breath-hold
or by correcting for motion
Insignificant motion compared to the spatial
resolution typically used (~2 mm).
Intrinsic SNR efficiency 1/3 of Brain (normal weight subjects); due
to larger distance from receiver coil
elements and larger noise volume
Imaging Concerns Imaging must be performed during
quiescent cardiac phases.





Optimal Readouts For maximum myocardial signal:
Snapshot balanced SSFP
Single-shot EPI
For maximum gray/white matter signal:
Single-shot Spiral
Single-shot EPI
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between coil and tissue, and larger noise volume. This
SNR penalty is greater for overweight and obese subjects.
Finally, the optimal imaging methods must provide
highest possible tissue SNR efficiency, which is influ-
enced by T1 and T2, which are different for myocar-
dium compared to gray/white matter. These differences
are all critical for the design of ASL-CMR methods,
and for understanding how they subtly and significantly
differ from brain ASL methods.
Many of the fundamental developments in ASL
were first applied and validated in the brain. Of par-
ticular relevance, two signal models have been developed
for extracting tissue blood flow from ASL signals. The
“dual T1” approach by Detre et al. and the general kinetic
model by Buxton et al. have both been used in ASL-CMR
[27–29]. Methods for pulsed labeling, including methods
that balance magnetization transfer effects, were first de-
veloped in the brain and have been applied in ASL-CMR
[29, 30]. And several other methods have not yet been
successfully used in ASL-CMR, but show promise. These
include: background suppression (to reduce physiological
noise), velocity-selective labeling (to provide mea-
surements independent of transit delay), pseudo-
continuous labeling (to maximize labeling efficiency),
and simultaneous multi-slice imaging (to broaden
spatial coverage without increasing scan time).
From mouse to man
Interestingly, perfusion MRI including perfusion CMR
has gone in two completely different directions for
clinical and pre-clinical application. The reasons for
this become clear when comparing the major mor-
phologic, physiologic and MRI-technical factors that
differ between humans and rodents, summarized in
Table 2. Beyond the obvious differences in size, the
rodent heart is characterized by dramatically higher
heart rate, cardiac index and blood turnover in the
body. Another interesting difference is given by the
flow velocities in large vessels, which are indeed com-
parable between humans and rodents despite the dif-
ference in body size. Myocardial blood flow is roughly
five times higher in rodents than in humans. These
given facts have consequences for the design and the
feasibility of CMR techniques in rodents in general
and for perfusion CMR techniques in particular.
For first-pass CMR, the fact that blood circulation
times in rodents are very short requires short bolus
injection durations with high demand on the power
injector performance for generating a reproducible
shape. It also requires very rapid imaging techniques
for sampling the AIF with sufficient time resolution.
Fast imaging is also required due to the high heart
rates. 1st pass imaging in the mouse heart became in-
deed only feasible by the use of accelerated
acquisition techniques [7, 8]. Bolus injection volumes
in the mouse are of the order of 100 μL injected at a
flow rate of 2 mL/min [31]. A second difficulty is
given by the high capillary blood flow itself, which
produces rather sharp signal increases during first
pass. This makes the deconvolution techniques used
for perfusion quantification less reliable. Nevertheless,
an important advantage of first-pass techniques is
their speed. Reported acquisition times are of the
order of 60 s in the mouse heart [32].
For ASL-CMR in the rodent heart, the short blood
traveling times and high capillary blood flow are benefi-
cial, since the signal used for quantification is directly
proportional to MBF. It does not suffer from limitations
related to bolus sharpness and reproducibility, since the
generated magnetic labeling zone has a perfectly de-
fined shape and negligible duration. Since the labeling
can be unconditionally repeated, k-space acquisition
can be segmented, and the spatial resolution is there-
fore not limited by acquisition speed requirements.
However, even with the high MBF in rodents, the
produced contrast (approximately 20 %) is still much
lower than that produced by GBCA. Both the seg-
mentation used for producing high-resolution images
and the comparatively small signal therefore lead to
long acquisition times compared with first-pass CMR;
4–20 min have been reported [33–36]. In humans,
ASL-CMR is more challenging given the lower blood
flow values and heart rates. Also, since respiration
gating in humans is not as regular and reliable as in
animals, the scans are in general performed under
breath-hold, which limits the available acquisition time.
Table 2 Comparison of typical major cardiovascular features
between humans and rodents. The values for rats and mice are
average values typical for animals under isoflurane anesthesia.
The differences in blood recirculation time and capillary blood
flow have strong impact on the choice of methods for
measuring perfusion
Human Rat Mouse
Body weight 80 kg 0.3 kg 0.03 kg
Total blood volume 5 L 18 mL 1.8 mL
End diastolic volume (EDV) 180 mL 300 μL 50 μL
Myocardial Mass 150 g 0.6 g 0.1 g
Heart Rate 80 bpm 300 bpm 600 bpm
Cardiac Output 5 L/min 0.15 L/min 0.020 L/min
Time of recirculation 60 s 7 s 5 s
Aortic ejection
velocity [101–103]
100 cm/s 200 cm/s 300 cm/s
Breathing rate 12 bpm 70 bpm 110 bpm
Myocardial perfusion (MBF) 1 mL/g/min 5 mL/g/min 7 mL/g/min
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ASL-CMR in rodents
The feasibility of ASL was first demonstrated in the
rodent brain [27, 37], and application to the perfused
excised rat heart was also in the focus of the very
first ASL studies [38]. Since then, a significant
amount of work has been carried out on methods for
ASL-CMR in rodents in vivo.
Most studies have used the flow-sensitive alternating
inversion recovery (FAIR) scheme [39] consisting of a
pair of global and slice-selective inversion recovery ex-
periments Fig. 2. Combined with a Look-Locker readout
scheme (LLFAIR), absolute MBF quantification was
shown feasible by comparison of T1 relaxation times
measured with both experiments. The first successful re-
port of MBF mapping in rats by Belle et al. [33]
employed a LLFAIR snapshot-FLASH approach. These
authors used a two-compartment quantification model
that was initially setup with the goal to correct for errors
induced by perfusion on myocardial blood volume mea-
surements [40, 41], and which resulted in a slightly
modified relation between perfusion and slice-selective
and global inversion tissue T1 values from the initial
Detre relation [27]. The study was done in animals
under artificial respiration that was arrested during
image acquisition to avoid artifacts.
More recent efforts have improved the robustness of
MBF quantification using a respiration- and ECG-gated
LLFAIRGE single-gradient echo technique [34, 42],
which allowed for higher spatial resolutions, freely
breathing animals and reduced blurring. These improve-
ments were particularly useful in the mouse heart, which
features very high heart rates making snapshot acquisi-
tions prone to blurring [43]. As a drawback, this led to
significantly increased measurement times of about
25 min. An example showing the magnetization recovery
for two different regions of interest in a mouse is shown
in Fig. 3. It can be seen that the Look-Locker approach
is advantageous in a small animal context, since – owing
to the high heart rate - magnetization recovery can be
sampled with good temporal resolution. One more re-
cent improvement of LLFAIRGE incorporated better
handling of respiratory motion and heart rate variations
using fuzzy C-means clustering but did not shorten the
acquisition duration [44].
Campbell-Washburn et al. have suggested several
improvements of LLFAIRGE. A segmented k-space
Fig. 2 The FAIR labeling scheme (upper part) consists in two inversion recovery measurements. In the first measurement the labeling zone is only
around the imaging slice, and in the second measurement the inversion is global. FAIR is the most commonly used ASL technique in the heart.
The timing of the inversion and that of the readout modules should be ECG-gated and occur in the same cardiac phase. The Look-Locker
inversion-recovery readout (lower part) has been used mainly (although not exclusively) in the rodent heart, where the rapid heart rate
permits dense sampling of the magnetization recovery curve. Due to the lower heart rate in humans, only one readout at a specific inversion
time is generally performed
Kober et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:22 Page 5 of 16
acquisition was done using a data logger in addition for
recording individual repetition times [35]. The same
group also showed the feasibility of multi-slice ASL in
mice [45] using a segmented LLFAIR method, in which
they also concentrated on ways to take into account the
influence of partial saturation of the LV chamber blood
by the image acquisition itself. Finally, a detailed analysis
of potential error sources in LLFAIR measurements has
recently been published by Kampf et al. [46].
Abeykoon et al. [47] proposed a single-inversion-time
FAIR-ASL method instead of the T1-based methods used
beforehand. Similar approaches had been used earlier, but
in the human heart [48]. In the mouse heart, the authors
found lower standard deviations within myocardial re-
gions of interest on the perfusion maps than with the
well-established LLFAIRGE technique, while absolute
quantification of MBF led to similar values.
The FAIR technique is a pulsed ASL (PASL)
technique, which has limited acquisition efficiency
compared with the continuous ASL (CASL) techniques
well known from brain studies [37]. To benefit from
the sensitivity advantages of CASL in CMR applica-
tions, a steady-pulsed ASL (spASL) scheme using a cine
readout incorporating one labeling pulse per cardiac
cycle (cine-ASL) was suggested [36, 49]. This steady-
pulsed ASL method was shown to allow shorter acqui-
sition times (8 min) than the LLFAIR technique while
preserving signal to noise ratio, spatial resolution and ro-
bustness with respect to cardiac motion, since no k-space
segmentation was used. Unlike other continuous ASL
Fig. 3 Look-Locker FAIR recovery signal behavior in myocardial and chest muscle regions in a mouse at 4.7 T (magnitude data, symbols represent
the average of pixel signals in each ROI after global or slice-selective inversion, continuous line is an exponential fit for T1gl and T1sl). The signal
difference due to perfusion is nearly absent in the very weakly perfused chest muscle, whereas myocardium shows a clear difference in relaxation.
Data: CRMBM Marseille
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techniques, a drawback of cine-ASL is that a separate T1
measurement is necessary for absolute quantification,
but it is an efficient technique in particular when re-
peated measurements are required during a single
exam, such as in rest/stress comparisons. This tech-
nique was also shown to be able to detect perfusion
variations across the cardiac cycle [50].
Validation studies
All small animal ASL-CMR validation studies to-date
were performed in rats. Waller et al. [51] provided
validation of the snapshot-FLASH FAIR Look Locker
technique against microspheres in pentobarbital-
anesthetized rats at rest and under adenosine stress
and found good correlation between both techniques.
Jacquier et al. [52] validated the LLFAIRGE technique
in rats under isoflurane anesthesia at rest and under
stress, although in two different groups of animals
undergoing MRI and microsphere surgery. The latter
study reported much larger perfusion reserve and
MBF, which was attributed to the differences in the
anesthetics used. However, quantitative MBF values
were similar between microspheres and ASL-CMR.
First-pass CMR in rodents
Despite the technical challenges, small-animal first-pass
bolus tracking techniques were recently shown feasible
thanks to efforts made in accelerating image acquisition.
Makowski et al. [53] introduced a k-t SENSE technique
for rodent myocardial blood flow (MBF) measurements
on a clinical 3 T scanner. First-pass CMR was performed
based on a saturation recovery spoiled gradient echo
method with 10-fold k-space and time domain undersam-
pling (k-t PCA, [54]), and the technique was validated in
healthy mice by comparison with fluorescent micro-
spheres [55] at rest and during dipyridamole-induced
vasodilator stress. In parallel, Coolen et al. [32] proposed
another approach using a four-element detection coil and
GRAPPA k-space acceleration allowing for semi-
quantitative assessment of the myocardial perfusion status.
Naresh and coworkers recently used BLOSM-accelerated
1st pass CMR to study myocardial blood flow in a high-
sucrose diet diabetic mouse model [56]. The same group
has provided a systematic comparison of this approach
with a FAIR Look-Locker technique in terms of image
quality, quantification and reproducibility [57].
Performance
Among the published methods, it is difficult to identify a
method of choice in general terms. Table 3 provides an
overview over the major published methods along with
their advantages and drawbacks. In a recent study by
Naresh et al. [57], a BLOSM-accelerated 1st pass tech-
nique was compared with a FAIR-spiral ASL tech-
nique pointing out that 1st pass CMR had advantages
in low blood flow situations whereas ASL gave better
perfusion mapping quality and better reproducibility
when high blood flow was high.
Interesting recent findings
There are a number of examples using ASL in rodent
models of cardiovascular disease. The topic of infarction
and the role of microcirculation in infarction has been
extensively studied particularly in rat models [51, 58, 59].
Among the more recent ones, Vandsburger et al. [60] have
studied MBF along with many other parameters including
regional function in a nNOS-/- knockout mouse model.
They found normal perfusion reserve under β-adrenergic
stimulation despite a severely altered functional response.
In another study, both relaxation times and perfusion
were analyzed in spontaneously hypertensive rats at vari-
ous stages of the disease [61]. Along with correlations of
T1 and T2 with fibrotic content obtained by histology, the
authors showed that MBF decreased in hypertensive rats
without any correlation between perfusion and capillary
density of the myocardium. Namely, anti-hypertensive
therapy was shown to produce a significant improvement
of myocardial perfusion in this model.
Several studies focusing on the infarcted heart made
use of LLFAIR ASL. For example, the impact of endo-
thelial cell transplantation in the infarcted myocardium
was investigated by Zhang et al. [62]. MBF was
Table 3 Rodent ASL-CMR methods used in different studies along with their advantages and drawbacks
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quantified with and without transplantation of human
endothelial cells into the infarcted heart, and a signifi-
cant perfusion increase was observed in the treated
hearts. This perfusion improvement was thus accompan-
ied by an increase of microvasculature density in the in-
farcted regions. ASL CMR was also able to show
improved myocardial perfusion after myocardial infarc-
tion in mice with PTP1B deficiency. The improved per-
fusion was likely due to an enhancement of angiogenesis
in this genetically modified mouse model [63].
Absolute MBF quantification using LLFAIR was
shown to be a unique and sensitive index to evaluate
therapy in rodent heart disease models. Another ther-
apy based on soluble epoxide hydrolase inhibition,
which increases cardiovascular protective acids, has
been shown to exert beneficial effects in a chronic
heart failure model [64]. Increased perfusion in in-
farcted myocardium was found to be a short-term
process preceding the long-term effects of LV remod-
eling. In a study exploring overstimulation of the rat
heart by chronic infusion of isoproterenol, perfusion
was shown to accompany the strong workload in-
crease only temporarily, such that a chronic mismatch
between workload and oxygen supply occurred, which
resulted in reduced cardiac performance after one
week of isoproterenol administration [65] (Fig. 4).
More recently, the quantification capabilities of ASL have
been used in a longitudinal study using multiple CMR
modalities in a high-fat high-sucrose mouse model of type
2 diabetes [66] to monitor microvascular changes induced
by the modified diet.
ASL-CMR in large animals and humans
A different set of ASL pulse sequences are used in large
animals and humans because of their vastly lower heart
rates and perfusion when compared to small animals;
these sequences are summarized in Table 4.
The first published ASL studies in the human heart
were independently carried out by Poncelet et al. [67]
and Wacker et al. [68]. Poncelet et al. used a FAIR-
EPI technique on a clinical 3 T system with a single-
loop receive coil. Two cardiac-gated EPI readouts
were performed after slice-selective and global inver-
sion pulses, and the individual inversion times were
recorded and used in the quantification model. The
authors used the original quantification model by
Table 4 Large Animal and Human ASL-CMR methods used in different studies. To date, with exception of the spASL technique, all
studies used the FAIR labeling approach combined with different readout strategies
Author Year Post-labeling delay Labeling method Imaging method Quantification
Capron [75] 2014 HR dependent spASL bSSFP spASL
Wang [20] 2010 200 - 1700 ms FAIR bSSFP Signal Difference
Zun [48] 2009 1 RR FAIR bSSFP Signal Difference
Northrup [76] 2007 (1-12)RR + 91-177 ms FAIR GRE Dual T1
Wacker [69] 2003 100 -1400 ms FAIR-sat FLASH Dual T1
Poncelet [67] 1999 1 RR FAIR EPI Signal Difference
Fig. 4 Myocardial perfusion and cardiac function under continuous isoproterenol administration in rats. Both perfusion and function are strongly
increased by this inotropic agent shortly after infusion start (day 1). The strong contractility is sustained over seven days while perfusion
diminishes to lower values leading to morphological alterations at longer term (adapted from Desrois et al. [65])
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Detre et al. [27] approximating relaxation times of
blood and tissue as equal. Physiological noise was
assessed and considered as a major challenge. The se-
quence was also used in pigs under rest and stress
conditions, and the ASL results were compared with
microspheres showing a moderate correlation. As a
result, the technique was considered to give reliable
measurements, but only under pharmacologic stress
conditions, in which blood flow is high. In parallel,
Wacker and coworkers published ASL-CMR data
from humans using a saturation-recovery snapshot
FLASH technique at 1.5 T using a 4-channel array.
They performed 9 cardiac-gated readouts per slice-
selective or global saturation and used a slightly
modified approach for quantification via fitted global
and slice-selective T1 values [33]. In a second study,
Wacker et al. [69] used a similar technique at 2 Tesla
in CAD patients and were able to show reduced per-
fusion reserve in affected myocardial territories.
Zun et al. [48] later provided an experimental meas-
urement metric for physiological noise based on signal
variation across repetitions. They employed a single-TI
FAIR bSSFP technique at 3 T. Wang et al. [20] employed
a similar but navigator-gated approach with FAIR label-
ing under free breathing conditions. They used a non-
rigid motion correction algorithm inspired from 1st pass
CMR perfusion sequences to correct for residual motion
[70]. The sequence was performed at multiple labeling
delay times to allow for simultaneous quantification of
myocardial blood flow and arterial transit time (ATT).
They reported resting perfusion values that compared fa-
vorably with perfusion values reported in the literature
from PET [71, 72] and first-pass perfusion MRI [73].
Miyazaki et al. adapted a time-spatial inversion pulse
(time-SLIP) for non-contrast angiography to ASL perfu-
sion at multiple labeling delay times followed by 3D
bSSFP imaging [74]. In the labeled condition, a non-
selective inversion was followed by a slice-selective in-
version centered on the aortic root while in the control
condition, a single non-selective inversion pulse was
used. They observed a transit time of 200–400 ms from
the aortic root to the imaging volume.
A new free-breathing labeling scheme called steady
pulsed ASL (spASL) was developed by Capron et al. [75]
for the heart that brought the advantage of high signal
to noise found in continuous ASL to a pulsed ASL tech-
nique. Labeling and snapshot bSSFP imaging were per-
formed every cardiac cycle during end-systole and mid-
diastole respectively to drive the perfusion signal to a
steady state. Two cardiac gated image series were ac-
quired under labeled and control conditions. The label-
ing slab was placed at the coronary root while the
control slab was placed symmetrically about the imaging
slice in a manner similar to EPISTAR. The authors
found that spASL had higher SNR compared to FAIR
while maintaining similar perfusion quantification. The
spASL method will, however, require further improve-
ments regarding motion management of labeling and ac-
quisition to become fully efficient.
Myocardial Blood Flow (MBF) quantification
Quantification of FAIR ASL falls into two main categor-
ies that either use a signal intensity difference method or
a dual T1 approach. Two variations of the difference
method have emerged. In its original implementation,
both the labeling pulse and the image acquisition were
gated to the same cardiac phase in consecutive heart-
beats. While this ensured that labeling and image acqui-
sition excited the same volume of heart, it also
introduced a changing labeling time (TI) from heart rate
variation that prevents direct subtraction of global and
slice-selective image pairs. Instead, myocardial data
along with two additional images at a short and long TI
were fit to a three parameter inversion recovery model
to generate a global and a slice-selective inversion recov-
ery curve [67]. The signal difference was subsequently
extrapolated at the average labeling time.
Zun et al. [48] and Wang et al. [20] used a simplified
version of the difference method that kept the TI con-
stant between pairs of control and slice-selective images
[48]. The pulse sequence they used is shown in Fig. 5.
While this allows for direct subtraction of image pairs, it
is more susceptible to quantification errors when heart
rate variations are ≥ 4 bpm between image pairs (unpub-
lished data). Wang et al. [20] found that non-rigid mo-
tion correction was able to mitigate quantification error
and improve reliability.
The dual T1 approach to perfusion quantification was
first formulated by Detre et al. [27] and experimentally
verified by Bauer et al. [41] in an isolated perfused cardi-
oplegic rat heart. Wacker et al. [69] used a saturation re-
covery FLASH sequence at nine different saturation
delays for T1 quantification. They reported overesti-
mated perfusion values, potentially related to the fact
that the labeling saturation was done in varying cardiac
phases. Northrup et al. [76] used a Look-Locker inversion
recovery sequence to ensure that labeling and imaging
occurred in the same cardiac phase. However, the au-
thors noted that in a study by Zhou et. al [77], dual T1
quantification can either underestimate or overestimate
FAIR perfusion in the presence of transit delay while the
difference approach can only underestimate perfusion.
Quantification of perfusion with spASL [49] takes into
account the influence of multiple labeling pulses that are
applied to blood as it travels from the left ventricular
blood pool to the capillary bed of the myocardium. The
steady state signal evolution changes depending on the
Kober et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:22 Page 9 of 16
image acquisition scheme and is incorporated into the
quantification equation. By acquiring a large number of
images, images that are mistriggered or corrupted by re-
spiratory motion can be rejected. Figure 6 compares the
pulse sequence of spASL and FAIR.
Registration
Image registration has proven to be an important step in
the analysis of ASL-CMR images, primarily because it is
a subtraction technique, so small spatial errors can result
in errors in perfusion quantification and/or increased
Fig. 5 ECG-gated FAIR Pulse Sequence Diagram with single inversion time readout mainly (but not exclusively) used in the human heart.
Labeling and imaging are placed in the same cardiac phase to ensure the same volume of myocardium is excited. Imaging is preceded
by a fat saturation and an initial preparation consisting of a catalyzation ramp to reduce transient oscillations
Fig. 6 Acquisition timing diagram for spASL and FAIR ASL-CMR. In spASL, labeling and imaging occur every heartbeat during end-systole
and mid-diastole, respectively. In FAIR, labeling and imaging occur in consecutive heartbeats at mid-diastole. An additional 6 sec wait is
required to allow for T1 recovery of the label before the next acquisition. spASL has approximately 5x higher scan efficiency than FAIR,
but is also more sensitive to gating errors and heart rate variability
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physiological noise. This is very important during free-
breathing acquisitions [20], but also has benefits during
breath-held acquisitions [78]. There are a variety of
established techniques for registering CMR images that
can be directly applied to ASL-CMR images [79–82].
Performance/interesting findings
In large animals, MBF measurements based on FAIR
Look-Locker gradient-echo ASL-CMR have correlated
well with microsphere histology [83]. Zhang et al. mea-
sured perfusion at rest and under dipyridamole induce
stress in two healthy dogs and four dogs with 70 % oc-
clusion to the left circumflex artery. Correlation between
MRI and microsphere measured perfusion were 0.9 and
0.63 for myocardium supplied by normal and stenotic
vessels respectively.
To date, ASL-CMR in humans has not been vali-
dated against a gold standard such as PET. However,
resting values have correlated well with PET litera-
ture, and the expected signal increases with stress
have been observed. In particular, 30–40 % increases
[84] were observed with isometric handgrip or leg
elevation and 3–5x increases [85] were observed with
vasodilation via intravenous adenosine. Zun et al. [86]
performed ASL-CMR in both healthy human volun-
teers and patients with suspected CAD and reported
clinically relevant changes in myocardial blood flow
with vasodilation. Myocardial territories with low per-
fusion reserve (MBFstress/MBFrest) were also validated
with coronary angiography. Two examples of CAD
within the LAD and RCA found by ASL-CMR with
their corresponding coronary angiograms are shown
in Fig. 7. Perfusion reserve in normal and ischemic
myocardial perfusion territories in 11 patients are
shown in Fig. 8.
Northrup et al. [76] repeated ASL-CMR scans at 1.5 T
and 3 T, and showed that although 3 T provided higher
SNR (signal-to-thermal-noise ratio), it did not provide
higher temporal SNR (signal-to-physiological-noise ratio).
This interesting study suggests that unresolved sources of
physiological noise limit sensitivity of ASL-CMR; an idea
that was confirmed by a recent finding that shortening the
imaging window via parallel imaging provides improved
temporal SNR despite lower SNR [87]. Physiological
noise remains as one of the important factors limiting
sensitivity of the technique. Even small amounts of car-
diac or respiratory motion can significantly corrupt the
ASL difference image because inflowing blood signal is
significantly smaller than background myocardial tissue
signal. Most studies have tried to reduce physiological
noise from cardiac and respiratory motion through
breath-held, rapid single shot imaging during a stable
cardiac phase. Physiological noise is measured as the
variance of MBF from individual control and labeled
image pairs. This calculation is straightforward using
the signal intensity difference method at a single TI.
Zun et al. [48] reported that physiological noise was
0.23 ml/g/min in 15 healthy volunteers. Physiological
noise using the dual T1 approach is not directly mea-
sured because MBF from individual image pairs are
never determined. Instead a surrogate for physiological
noise is calculated from residuals of T1 curve fitting.
Open questions
Absolute quantification and error sources
Quantification is a strength of ASL-CMR compared
to first-pass techniques. The models as well as the
post-processing algorithms are comparatively simple,
since only water molecules are involved in the
process, and since the labeling pulses create a per-
fectly reproducible bolus of well-known shape that is
placed close to the imaged region. However, some un-
certainties remain. Among them, the arterial transit
time (ATT) from the labeled region to the entry of
Fig. 7 ASL-CMR in patients with single-vessel CAD. Patient with total LAD occlusion shows reduced perfusion reserve by (a) ASL consistent with
(b) angiography (red arrows). Patient with total RCA occlusion shows reduced perfusion reserve by (c) ASL consistent with (d) angiography
(green arrows). The myocardial perfusion reserve (MPR) color scale represents 0.0 – 2.0 ml/g/min. (Data from Zun Z, et al. JACC: Cardiovasc
Imag 2011, 4:1253–1261)
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the capillary system may vary as a function of phy-
siology. ATT becomes a significant source of error
when it is much longer than the labeling delay time.
Multi-delay protocols mitigate this source of error
and can derive both ATT and MBF [20, 74]. The la-
beling efficiency affects the absolute MBF calculation
in a direct proportional way. While variations of the
labeling efficiency are likely negligible for the FAIR
technique, the spASL technique is more prone to
such errors. Other error sources are potential varia-
tions in T1 of tissue and blood if they are not mea-
sured along with perfusion. T1 variations in blood
may be caused by differences in hematocrit.
Complete coverage during stress
Current large animal and human ASL-CMR methods
can capture a single slice in roughly 3 min of scan time.
This has made it difficult to perform a comprehensive
evaluation of ischemic disease which would require
covering all coronary territories during the typical dur-
ation of peak vasodilation during a pharmacologic
stress test (roughly 3 min for adenosine, less for regade-
nosin). The use of accelerated acquisition schemes in-
cluding simultaneous multislice imaging [88, 89] or
undersampled 3D acquisition [90–92] may be able to
address this current limitation.
High field imaging
Due to the increasing T1 with field strength, the life
time of the magnetic labeling increases as well, and ASL
is therefore a technique doubly benefiting from higher
field in theory. This advantage is, however, compro-
mised and yet unclear when considering the im-
portant contribution of physiological noise identified
Fig. 8 ASL-CMR pilot study in patients with suspected CAD demonstrated that ASL detected clinically relevant increases in MBF associated with
vasodilation in (a) normal myocardium, and was able to differentiate those from (b) segments that were most ischemic based on
coronary angiography. (Data from Zun Z, et al. JACC: Cardiovasc Imag 2011, 4:1253–1261)
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earlier [48, 76]. Whether high or even ultra-high field
strengths (≥7 Tesla) can be used in a beneficial way
for ASL-CMR will strongly depend on the ability of
reducing motion contributions to signal variations ob-
served in the myocardium.
Motion correction
Beyond the most widely used ECG-triggered acquisition
under breath-hold, available motion management tech-
niques include post-processing image registration (rigid
or non-rigid), but also advanced real-time techniques
like motion tracking using a navigator. In ASL-CMR,
motion tracking may be applied not only to the imaging
slice, but it might also be useful to specific labeling
volumes such as 2D spatial RF inversions [93]. Finally,
advanced acquisition-reconstruction strategies like the
Generalized Reconstruction by Inversion of Coupled
Systems (GRICS) framework [94] directly integrate
motion information collected during the acquisition
into the reconstruction model and may be a way
towards more efficient ASL-CMR acquisitions in the
future.
Clinical applications
Due to its unlimited repeatability, ASL-CMR is an excel-
lent candidate for perfusion stress testing. The technique
can be used to assess and quantify regional myocardial
perfusion and perfusion reserve in CKD or ESRD pa-
tients who suffer from higher rates of cardiovascular
events, but cannot tolerate contrast agents required by
other perfusion imaging techniques. However, challenges
in applying ASL methods in the clinical setting remain.
Current ASL methods require precise timing of labeling
and imaging to the cardiac cycle, which is difficult to
perform in the setting of cardiac arrhythmias. Develop-
ments in self gated, ECG free CINE imaging can be ap-
plied to ASL to help overcome this limitation [95, 96]. In
disease processes with extremely low coronary flow such
as in heart failure, severe coronary stenosis, or high coron-
ary collateralization, ATT may be much longer that the la-
beling delay resulting in marked loss of the ASL signal.
Velocity selective arterial spin labeling, which is insensitive
to ATT by labeling blood based on its velocity within the
arterioles adjacent to tissue, have been used successfully in
the brain to and may be adapted for cardiac ASL [97, 98].
While not a direct measurement for viability and scar,
ASL can potentially detect regions of hypo-perfusion
associated with scar and can become a surrogate for
scar localization with improvements in the spatial
resolution of the technique. Figure 9 shows that rest
ASL-CMR is comparable with rest first-pass CMR at
detecting scar in a porcine model of myocardial infarc-
tion [99]. Finally, ASL-CMR may be used to assess dif-
fuse disease processes such as coronary microvascular
disease and diffuse interstitial fibrosis that result from
diabetes, hypertension, and cardiomyopathy because it
interrogates tissue perfusion directly.
Conclusion
ASL-CMR is a safe technique for mapping regional
myocardial perfusion and perfusion reserve. It does
not require any contrast agents, is compatible with
stress testing, and can be performed repeatedly and
even continuously, with no incremental risk to the
subject. ASL-CMR has been performed with great
success in small-animals, and is the current method
of choice when overall scan time is not a constraint.
Its application to large animals and humans has been
limited primarily by physiological noise (per-segment
measurement variation approximately ±0.2 ml/g/min).
It remains an active area of research, with many possible
solutions on the horizon. Successful developments in
brain ASL and small-animal ASL-CMR have helped to
inform many of the most recent developments in large
animal and human ASL-CMR.
Fig. 9 ASL-CMR in a pig with 4-week old septal infarct. a first-pass CMR image from peak myocardial enhancement. b Late Gadolinium
Enhanced image and c ASL MBF map at rest. The color scale ranges from 0-4 ml/g/min. The infarcted myocardium (blue arrows) is
thinned, and shows low MBF. Normal myocardium (yellow arrows) shows MBF of approximately 1.5 ml/g/min. (Data courtesy of Nilesh
Ghugre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada)
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space-time principle component analysis; k-t SENSE: k-space-time sensitivity
encoding; LLFAIR: Look-Locker flow-sensitive alternating inversion recovery;
LLFAIRGE: Look-Locker flow-sensitive alternating inversion recovery respiratory
gated; LV: left ventricle; MBF: myocardial blood flow; MBV: myocardial blood
volume; nNOS: neuronal nitric oxide synthase; PASL: pulsed arterial spin
labeling; PCASL: psuedo-continuous arterial spin labeling; PET: positron
emission tomography; PN: physiological noise; RF: radiofrequency;
SNR: signal - to - noise ratio; spASL: steady pulsed arterial spin labeling;
SPECT: single-photon emission computed tomography; SSFP: steady -
state free precession; Time-SLIP: time-spatial inversion pulse.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
FK: manuscript design, drafting, and revision, literature review, coordination
among co-authors, final revisions. TJ: literature review, manuscript drafting
and revision. TT: literature review, manuscript drafting and revision. KN:
manuscript design, drafting, and revision, literature review, coordination
among co-authors. All authors read and approved the manuscript.
Acknowledgements
We thank our many collaborators and funding sources. F.K. and T.T. thank
Thibaut Capron, Julien Pugnaire, Monique Bernard, and funding from Centre
National de la Recherche Scientifique (CNRS-UMR7339), Agence Nationale de
la Recherche (ANR-14-CE17-0016-01 COFLORES) and Fondation de la Recherche
Médicale (DBS20140930772). K.S.N. and T.J. thank Zungho Zun, Eric
Wong, Gerald Pohost, Ramdas Pai, Padmini Varadarajan, Hung Phi Do,
Vanessa Landes, Ahsan Javed, Andrew Yoon, and funding from the
Wallace H. Coulter Foundation (Phase 1 and Phase 2 Translational
Research Award) and American Heart Association (#13GRNT13850012).
We acknowledge support from the Visitor Program of the Ming Hsieh
Institute of the University of Southern California.
Author details
1Aix-Marseille Université, CNRS CRMBM UMR 7339, Centre de Résonance
Magnétique Biologique et Médicale, Marseille, France. 2Department of
Biomedical Engineering, University of Southern California, Los Angeles,
California, USA. 3Ming Hsieh Department of Electrical Engineering, University
of Southern California, Los Angeles, California, USA.
Received: 22 December 2015 Accepted: 22 March 2016
References
1. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral
blood flow using magnetic resonance imaging techniques. J Cereb Blood
Flow Metab. 1999;19:701–35.
2. Wolf RL, Detre JA. Clinical neuroimaging using arterial spin-labeled
perfusion magnetic resonance imaging. Neurother J Am Soc Exp Neurother.
2007;4:346–59.
3. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O’Gara PT,
Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN,
Udelson JE, Kennedy JW, Verani MS,Williams KA, Antman EM, Smith SC,
Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP,Hunt SA, Fuster V,
Jacobs AK, Gibbons RJ, Russell RO, American College of Cardiology, American
Heart Association, et al. ACC/AHA/ASNC guidelines for the clinical use of
cardiac radionuclide imaging–executive summary: a report of the American
College of Cardiology/American Heart Association Task Force on Practice
Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the
Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318–33.
4. Ragosta M, Bishop AH, Lipson LC, Watson DD, Gimple LW, Sarembock IJ,
Powers ER. Comparison between angiography and fractional flow reserve
versus single-photon emission computed tomographic myocardial
perfusion imaging for determining lesion significance in patients with
multivessel coronary disease. Am J Cardiol. 2007;99:896–902.
5. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL.
Myocardial first-pass perfusion cardiovascular magnetic resonance: history,
theory, and current state of the art. J Cardiovasc Magn Reson. 2008;10:18.
6. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO,
Debl K, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T, MR-IMPACT
investigators. Superior diagnostic performance of perfusion-cardiovascular
magnetic resonance versus SPECT to detect coronary artery disease: The
secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic
Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery
Disease Trial). J Cardiovasc Magn Reson. 2012;14:61.
7. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K,
Schönberg SO, Luchner A, Strohm O, Ahlstrom H, Dill T, Hoebel N,
Simor T, MR-IMPACT Investigators. MR-IMPACT II: Magnetic resonance
imaging for myocardial perfusion assessment in coronary artery disease
trial: perfusion-cardiac magnetic resonance vs. single-photon emission
computed tomography for the detection of coronary artery disease: a
comparative multicentre, multivendor trial. Eur Heart J. 2013;34:775–81.
8. Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC,
Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S.
Cardiovascular magnetic resonance and single-photon emission computed
tomography for diagnosis of coronary heart disease (CE-MARC): a prospective
trial. Lancet Lond Engl. 2012;379:453–60.
9. Ritter CO, Wilke A, Wichmann T, Beer M, Hahn D, Köstler H. Comparison of
intravascular and extracellular contrast media for absolute quantification of
myocardial rest-perfusion using high-resolution MRI. J Magn Reson Imaging.
2011;33:1047–51.
10. Gatehouse PD, Elkington AG, Ablitt NA, Yang G-Z, Pennell DJ, Firmin DN.
Accurate assessment of the arterial input function during high-dose
myocardial perfusion cardiovascular magnetic resonance. J Magn Reson
Imaging JMRI. 2004;20:39–45.
11. Ishida M, Schuster A, Morton G, Chiribiri A, Hussain S, Paul M, Merkle N,
Steen H, Lossnitzer D, Schnackenburg B, Alfakih K, Plein S, Nagel E.
Development of a universal dual-bolus injection scheme for the
quantitative assessment of myocardial perfusion cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2011;13:28.
12. Larghat AM, Maredia N, Biglands J, Greenwood JP, Ball SG, Jerosch-
Herold M, Radjenovic A, Plein S. Reproducibility of first-pass
cardiovascular magnetic resonance myocardial perfusion. J Magn Reson
Imaging JMRI. 2013;37:865–74.
13. 2013 Atlas of CKD & ESRD [http://www.usrds.org/atlas.aspx]. Accessed date
15 Mar 2016.
14. ESRD Patients in 2012 A Global Perspective [http://www.vision-fmc.com/
files/pdf_2/ESRD_Patients_2012.pdf]. Accessed date 15 Mar 2016.
15. Di Angelantonio E. Chronic kidney disease and risk of major cardiovascular
disease and non-vascular mortality: prospective population based cohort
study. BMJ. 2010;341:c4986.
16. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease
and the risks of death, cardiovascular events, and hospitalization. N Engl J
Med. 2004;351:1296–305.
17. Cerqueira MD, Allman KC, Ficaro EP, Hansen CL, Nichols KJ, Thompson RC,
Van Decker WA, Yakovlevitch M. Recommendations for reducing radiation
exposure in myocardial perfusion imaging. J Nucl Cardiol. 2010;17:709–18.
18. Fazel R, Dilsizian V, Einstein AJ, Ficaro EP, Henzlova M, Shaw LJ. Strategies
for defining an optimal risk-benefit ratio for stress myocardial perfusion
SPECT. J Nucl Cardiol. 2011;18:385–92.
19. Lin EC. Radiation risk from medical imaging. Mayo Clin Proc. 2010;85:1142–6.
20. Wang DJ, Bi X, Avants BB, Meng T, Zuehlsdorff S, Detre JA. Estimation of
perfusion and arterial transit time in myocardium using free-breathing
myocardial arterial spin labeling with navigator-echo. Magn Reson Med.
2010;64:1289–95.
21. Bokkers RPH, Hernandez DA, Merino JG, Mirasol RV, van Osch MJ, Hendrikse J,
Warach S, Latour LL, National Institutes of Health Stroke Natural History
Investigators. Whole-brain arterial spin labeling perfusion MRI in patients with
acute stroke. Stroke J Cereb Circ. 2012;43:1290–4.
Kober et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:22 Page 14 of 16
22. Zaharchuk G. Arterial spin-labeled perfusion imaging in acute ischemic
stroke. Stroke. 2014;45:1202–7.
23. Wang J, Aguirre GK, Kimberg DY, Roc AC, Li L, Detre JA. Arterial spin
labeling perfusion fMRI with very low task frequency. Magn Reson Med.
2003;49:796–802.
24. Yang Y, Engelien W, Xu S, Gu H, Silbersweig DA, Stern E. Transit time,
trailing time, and cerebral blood flow during brain activation: Measurement
using multislice, pulsed spin-labeling perfusion imaging. Magn Reson Med.
2000;44:680–5.
25. Gonzalez-At JB, Alsop DC, Detre JA. Cerebral perfusion and arterial transit
time changes during task activation determined with continuous arterial
spin labeling. Magn Reson Med. 2000;43:739–46.
26. Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L,
Lu H, Macintosh BJ, Parkes LM, Smits M, van Osch MJP, Wang DJJ, Wong EC,
Zaharchuk G. Recommended implementation of arterial spin-labeled
perfusion MRI for clinical applications: A consensus of the ISMRM perfusion
study group and the european consortium for ASL in dementia. Magn
Reson Med. 2014;116(October 2013):102–16.
27. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson
Med. 1992;23:37–45.
28. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general
kinetic model for quantitative perfusion imaging with arterial spin labeling.
Magn Reson Med. 1998;40:383–96.
29. Wong EC. Quantifying CBF with pulsed ASL: technical and pulse sequence
factors. J Magn Reson Imaging JMRI. 2005;22:727–31.
30. Wong EC. An Introduction to ASL Labeling Techniques. J Magn Reson
Imaging JMRI. 2014.
31. van Nierop BJ, Coolen BF, Dijk WJR, Hendriks AD, de Graaf L, Nicolay K,
Strijkers GJ. Quantitative first-pass perfusion MRI of the mouse myocardium.
Magn Reson Med. 2013;69:1735–44.
32. Coolen BF, Moonen RP, Paulis LE, Geelen T, Nicolay K, Strijkers GJ. Mouse
myocardial first-pass perfusion MR imaging. Magn Reson Med.
2010;64:1658–63.
33. Belle V, Kahler E, Waller C, Rommel E, Voll S, Hiller K, Bauer W, Haase A. In
vivo quantitative mapping of cardiac perfusion in rats using a noninvasive
MR spin-labeling method. J Magn Reson Imaging. 1998;8:1240–5.
34. Kober F, Iltis I, Cozzone PJ, Bernard M. Myocardial blood flow mapping in
mice using high-resolution spin labeling magnetic resonance imaging:
influence of ketamine/xylazine and isoflurane anesthesia. Magn Reson Med.
2005;53:601–6.
35. Campbell-Washburn AE, Price AN, Wells JA, Thomas DL, Ordidge RJ,
Lythgoe MF. Cardiac arterial spin labeling using segmented ECG-gated
Look-Locker FAIR: variability and repeatability in preclinical studies. Magn
Reson Med. 2013;69:238–47.
36. Troalen T, Capron T, Cozzone PJ, Bernard M, Kober F. Cine-ASL: A steady-
pulsed arterial spin labeling method for myocardial perfusion mapping in
mice. Part I. Experimental study. Magn Reson Med. 2013;70:1389–98.
37. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging
of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U A.
1992;89:212–6.
38. Williams DS, Grandis DJ, Zhang W, Koretsky AP. Magnetic resonance
imaging of perfusion in the isolated rat heart using spin inversion of arterial
water. Magn Reson Med. 1993;30:361–5.
39. Kim SG. Quantification of relative cerebral blood flow change by flow-sensitive
alternating inversion recovery (FAIR) technique: application to functional
mapping. Magn Reson Med. 1995;34:293–301.
40. Bauer WR, Hiller KH, Roder F, Rommel E, Ertl G, Haase A. Magnetization
exchange in capillaries by microcirculation affects diffusion-controlled spin-
relaxation: a model which describes the effect of perfusion on relaxation
enhancement by intravascular contrast agents. Magn Reson Med. 1996;35:43–55.
41. Bauer WR, Roder F, Hiller KH, Han H, Fröhlich S, Rommel E, Haase A, Ertl G. The
effect of perfusion on T1 after slice-selective spin inversion in the isolated
cardioplegic rat heart: measurement of a lower bound of intracapillary-
extravascular water proton exchange rate. Magn Reson Med. 1997;38:917–23.
42. Kober F, Iltis I, Cozzone PJ, Bernard M. Cine-MRI assessment of cardiac
function in mice anesthetized with ketamine/xylazine and isoflurane.
Magn Reson Mater Phys Biol Med. 2004;17:157–61.
43. Streif JU, Nahrendorf M, Hiller KH, Waller C, Wiesmann F, Rommel E, Haase A,
Bauer WR. In vivo assessment of absolute perfusion and intracapillary blood
volume in the murine myocardium by spin labeling magnetic resonance
imaging. Magn Reson Med. 2005;53:584–92.
44. Vandsburger MH, Janiczek RL, Xu Y, French BA, Meyer CH, Kramer CM,
Epstein FH. Improved arterial spin labeling after myocardial infarction in
mice using cardiac and respiratory gated look-locker imaging with fuzzy
C-means clustering. Magn Reson Med. 2010;63:648–57.
45. Campbell-Washburn AE, Zhang H, Siow BM, Price AN, Lythgoe MF, Ordidge RJ,
Thomas DL. Multislice cardiac arterial spin labeling using improved myocardial
perfusion quantification with simultaneously measured blood pool input
function. Magn Reson Med. 2013;70:1125–36.
46. Kampf T, Helluy X, Gutjahr FT, Winter P, Meyer CB, Jakob PM, Bauer WR,
Ziener CH. Myocardial perfusion quantification using the T1-based FAIR-ASL
method: The influence of heart anatomy, cardiopulmonary blood flow and
look–locker readout. Magn Reson Med. 2013.
47. Abeykoon S, Sargent M, Wansapura JP. Quantitative myocardial perfusion in
mice based on the signal intensity of flow sensitized CMR. J Cardiovasc
Magn Reson. 2012;14:73.
48. Zun Z, Wong EC, Nayak KS. Assessment of myocardial blood flow (MBF) in
humans using arterial spin labeling (ASL): Feasibility and noise analysis.
Magn Reson Med. 2009;62:975–83.
49. Capron T, Troalen T, Cozzone PJ, Bernard M, Kober F. Cine-ASL: A steady-
pulsed arterial spin labeling method for myocardial perfusion mapping in
mice. Part II. Theoretical model and sensitivity optimization. Magn Reson
Med. 2013;70:1399–408.
50. Troalen T, Capron T, Bernard M, Kober F. In vivo characterization of rodent
cyclic myocardial perfusion variation at rest and during adenosine-induced
stress using cine-ASL cardiovascular magnetic resonance. J Cardiovasc
Magn Reson. 2014;16:18.
51. Waller C, Kahler E, Hiller K-H, Hu K, Nahrendorf M, Voll S, Haase A, Ertl G,
Bauer WR. Myocardial Perfusion and Intracapillary Blood Volume in Rats at
Rest and with Coronary Dilatation: MR Imaging in Vivo with Use of a
Spin-Labeling Technique1. Radiology. 2000;215:189–97.
52. Jacquier A, Kober F, Bun S, Giorgi R, Cozzone PJ, Bernard M. Quantification
of myocardial blood flow and flow reserve in rats using arterial spin labeling
MRI: comparison with a fluorescent microsphere technique. NMR Biomed.
2011;24:1047–53.
53. Makowski M, Jansen C, Webb I, Chiribiri A, Nagel E, Botnar R, Kozerke S,
Plein S. First-pass contrast-enhanced myocardial perfusion MRI in mice on a
3-T clinical MR scanner. Magn Reson Med. 2010;64:1592–8.
54. Pedersen H, Kozerke S, Ringgaard S, Nehrke K, Kim WY. k-t PCA: temporally
constrained k-t BLAST reconstruction using principal component analysis.
Magn Reson Med. 2009;62:706–16.
55. Jogiya R, Makowski M, Phinikaridou A, Patel AS, Jansen C, Zarinabad N, Chiribiri A,
Botnar R, Nagel E, Kozerke S, Plein S. Hyperemic stress myocardial perfusion
cardiovascular magnetic resonance in mice at 3 Tesla: initial experience and
validation against microspheres. J Cardiovasc Magn Reson. 2013;15:62.
56. Naresh NK, Chen X, Roy RJ, Antkowiak PF, Annex BH, Epstein FH. Accelerated
dual-contrast first-pass perfusion MRI of the mouse heart: development and
application to diet-induced obese mice. Magn Reson Med. 2015;73:1237–45.
57. Naresh NK, Chen X, Moran E, Tian Y, French BA, Epstein FH. Repeatability
and variability of myocardial perfusion imaging techniques in mice:
Comparison of arterial spin labeling and first-pass contrast-enhanced MRI:
Repeatability and Variability of First-Pass MRI and ASL in Mice. Magn Reson
Med 2015:n/a–n/a. doi:10.1002/mrm.25769. [Epub ahead of print]
58. Waller C, Hiller KH, Kahler E, Hu K, Nahrendorf M, Voll S, Haase A, Ertl G,
Bauer WR. Serial magnetic resonance imaging of microvascular remodeling
in the infarcted rat heart. Circulation. 2001;103:1564–9.
59. Hiller KH, Ruile P, Kraus G, Bauer WR, Waller C. Tissue ACE inhibition
improves microcirculation in remote myocardium after coronary stenosis:
MR imaging study in rats. Microvasc Res. 2010;80:484–90.
60. Vandsburger MH, French BA, Helm PA, Roy RJ, Kramer CM, Young AA,
Epstein FH. Multi-parameter in vivo cardiac magnetic resonance imaging
demonstrates normal perfusion reserve despite severely attenuated beta-
adrenergic functional response in neuronal nitric oxide synthase knockout
mice. Eur Heart J. 2007;28:2792–8.
61. Caudron J, Mulder P, Nicol L, Richard V, Thuillez C, Dacher J-N. MR
relaxometry and perfusion of the myocardium in spontaneously
hypertensive rat: correlation with histopathology and effect of anti-
hypertensive therapy. Eur Radiol. 2013;23:1871–81.
62. Zhang H, Qiao H, Frank RS, Huang B, Propert KJ, Margulies S, Ferrari VA,
Epstein JA, Zhou R. Spin-labeling magnetic resonance imaging detects
increased myocardial blood flow after endothelial cell transplantation in the
infarcted heart. Circ Cardiovasc Imaging. 2012;5:210–7.
Kober et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:22 Page 15 of 16
63. Besnier M, Galaup A, Nicol L, Henry J-P, Coquerel D, Gueret A, Mulder P,
Brakenhielm E, Thuillez C, Germain S, Richard V, Ouvrard-Pascaud A. Enhanced
angiogenesis and increased cardiac perfusion after myocardial infarction in
protein tyrosine phosphatase 1B-deficient mice. FASEB J. 2014;28:3351–61.
64. Merabet N, Bellien J, Glevarec E, Nicol L, Lucas D, Remy-Jouet I, Bounoure F,
Dreano Y, Wecker D, Thuillez C, Mulder P. Soluble epoxide hydrolase
inhibition improves myocardial perfusion and function in experimental
heart failure. J Mol Cell Cardiol. 2012;52:660–6.
65. Desrois M, Kober F, Lan C, Dalmasso C, Cole M, Clarke K, Cozzone PJ,
Bernard M. Effect of isoproterenol on myocardial perfusion, function, energy
metabolism and nitric oxide pathway in the rat heart - a longitudinal MR
study. NMR Biomed. 2014;27:529–38.
66. Abdesselam I, Pepino P, Troalen T, Macia M, Ancel P, Masi B, Fourny N,
Gaborit B, Giannesini B, Kober F, Dutour A, Bernard M. Time course of
cardiometabolic alterations in a high fat high sucrose diet mice model and
improvement after GLP-1 analog treatment using multimodal cardiovascular
magnetic resonance. J Cardiovasc Magn Reson. 2015;17.
67. Poncelet BP, Koelling TM, Schmidt CJ, Kwong KK, Reese TG, Ledden P,
Kantor HL, Brady TJ, Weisskoff RM. Measurement of human myocardial
perfusion by double-gated flow alternating inversion recovery EPI. Magn
Reson Med. 1999;41:510–9.
68. Wacker CM, Bock M, Hartlep AW, Beck G, van Kaick G, Ertl G, Bauer WR,
Schad LR. Changes in myocardial oxygenation and perfusion under
pharmacological stress with dipyridamole: assessment using T*2 and T1
measurements. Magn Reson Med. 1999;41:686–95.
69. Wacker CM, Fidler F, Dueren C, Hirn S, Jakob PM, Ertl G, Haase A, Bauer WR.
Quantitative assessment of myocardial perfusion with a spin-labeling
technique: preliminary results in patients with coronary artery disease.
J Magn Reson Imaging. 2003;18:555–60.
70. Chefd’Hotel C, Hermosillo G, Faugeras O. Flows of Diffeomorphisms for
Multimodal Image Registration. Proc IEEE Int Symp Biomed Imaging
ISBI’2002 Wash DC USA 2002 2004:753–756.
71. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of
resting and hyperemic myocardial blood flow in healthy humans.
Cardiovasc Res. 2001;50:151–61.
72. Schepis T, Gaemperli O, Treyer V, Valenta I, Burger C, Koepfli P, Namdar M,
Adachi I, Alkadhi H, Kaufmann PA. Absolute quantification of myocardial blood
flow with 13 N-ammonia and 3-dimensional PET. J Nucl Med. 2007;48:1783–9.
73. Hsu L-Y, Rhoads KL, Holly JE, Kellman P, Aletras AH, Arai AE. Quantitative
myocardial perfusion analysis with a dual-bolus contrast-enhanced first-pass
MRI technique in humans. J Magn Reson Imaging JMRI. 2006;23:315–22.
74. Miyazaki M, Zhou X, Hoshino T, Yokoyama K, Ishimura R, Nitatori T. Non-contrast
myocardial perfusion using a novel 4D magnetic resonance arterial spin labeling
technique: initial experience. Microvasc Res. 2015;98:94–101.
75. Capron T, Troalen T, Robert B, Jacquier A, Bernard M, Kober F. Myocardial
perfusion assessment in humans using steady-pulsed arterial spin labeling:
Human MBF Using Steady-Pulsed Arterial Spin Labeling. Magn Reson Med.
2015;74:990–8.
76. Northrup BE, McCommis KS, Zhang H, Ray S, Woodard PK, Gropler RJ,
Zheng J. Resting myocardial perfusion quantification with CMR arterial spin
labeling at 1.5 T and 3.0 T. J Cardiovasc Magn Reson. 2008;10:53.
77. Zhou J, van Zijl PC. Effect of transit times on quantification of cerebral
blood flow by the FAIR T(1)-difference approach. Magn Reson Med. 1999;42:
890–4.
78. Javed A, Jao TR, Nayak KS. Motion correction facilitates the automation of
cardiac ASL perfusion imaging. J Cardiovasc Magn Reson. 2015;17 Suppl 1:51.
79. Chefd’Hotel C, Hermosillo G, Faugeras O. Flows of Diffeomorphisms for
Multimodal Image Registration. Proc IEEE Int Symp Biomed Imaging. In Proc
IEEE Int Symp Biomed Imaging (ISBI’2002). Washington D.C.: IEEE. http://
ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=1029367&url=http%3A%
2F%2Fieeexplore.ieee.org%2Fxpls%2Fabs_all.jsp%3Farnumber%3D1029367.
80. Kellman P, Chefd’hotel C, Lorenz CH, Mancini C, Arai AE, McVeigh ER. Fully
automatic, retrospective enhancement of real-time acquired cardiac cine
MR images using image-based navigators and respiratory motion-corrected
averaging. Magn Reson Med. 2008;59:771–8.
81. Kellman P, Chefd’hotel C, Lorenz CH, Mancini C, Arai AE, McVeigh ER. High
spatial and temporal resolution cardiac cine MRI from retrospective
reconstruction of data acquired in real time using motion correction and
resorting. Magn Reson Med. 2009;62:1557–64.
82. Avants BB, Tustison NJ, Johnson HJ. Advanced Normalization Tools (ANTS).
Available from: http://stnava.github.io/ANTs/. Accessed date 01 Apr 2016.
83. Zhang H, Shea SM, Park V, Li D, Woodard PK, Gropler RJ, Zheng J. Accurate
myocardial T1 measurements: toward quantification of myocardial blood
flow with arterial spin labeling. Magn Reson Med. 2005;53:1135–42.
84. Lowe DK, Rothbaum DA, McHenry PL, Corya BC, Knoebel SB. Myocardial
blood flow response to isometric (handgrip) and treadmill exercise in
coronary artery disease. Circulation. 1975;51:126–31.
85. Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, Phelps ME,
Schelbert HR. Comparison of maximal myocardial blood flow during
adenosine infusion with that of intravenous dipyridamole in normal men.
J Am Coll Cardiol. 1992;20:979–85.
86. Zun Z, Varadarajan P, Pai RG, Wong EC, Nayak KS. Arterial Spin Labeled CMR
Detects Clinically Relevant Increase in Myocardial Blood Flow With
Vasodilation. JACC Cardiovasc Imaging. 2011;4:1253–61.
87. Do HP, Jao TR, Nayak KS. Myocardial arterial spin labeling perfusion imaging
with improved sensitivity. J Cardiovasc Magn Reson. 2014;16:15.
88. Lau AZ, Tunnicliffe EM, Frost R, Koopmans PJ, Tyler DJ, Robson MD.
Accelerated human cardiac diffusion tensor imaging using simultaneous
multislice imaging. Magn Reson Med. 2015;73:995–1004.
89. Stäb D, Ritter CO, Breuer FA, Weng AM, Hahn D, Köstler H. CAIPIRINHA
accelerated SSFP imaging. Magn Reson Med. 2011;65:157–64.
90. Larson AC, Simonetti OP, Li D. Coronary MRA with 3D undersampled
projection reconstruction TrueFISP. Magn Reson Med. 2002;48:594–601.
91. Peters DC, Ennis DB, Rohatgi P, Syed MA, McVeigh ER, Arai AE. 3D
breath-held cardiac function with projection reconstruction in steady
state free precession validated using 2D cine MRI. J Magn Reson
Imaging. 2004;20:411–6.
92. Stehning C, Börnert P, Nehrke K, Eggers H, Stuber M. Free-breathing
whole-heart coronary MRA with 3D radial SSFP and self-navigated
image reconstruction. Magn Reson Med. 2005;54:476–80.
93. Zun Z, Wong EC, Nayak KS. Myocardial ASL perfusion imaging using
pulsed 2D tagging of the proximal aorta. Proc Intl Soc Mag Reson Med.
2009;17:1737.
94. Odille F, Vuissoz P-A, Marie P-Y, Felblinger J. Generalized Reconstruction by
Inversion of Coupled Systems (GRICS) applied to free-breathing MRI.
Magn Reson Med. 2008;60:146–57.
95. Liu J, Spincemaille P, Codella NCF, Nguyen TD, Prince MR, Wang Y.
Respiratory and cardiac self-gated free-breathing cardiac CINE imaging
with multiecho 3D hybrid radial SSFP acquisition. Magn Reson Med.
2010;63:1230–7.
96. Han F, Zhou Z, Rapacchi S, Finn PJ, Hu P. Segmented golden ratio radial
reordering for dynamic cardiac MRI with variable temporal resolution.
J Cardiovasc Magn Reson. 2015;17 Suppl 1:Q124.
97. Wong EC, Cronin M, Wu W-C, Inglis B, Frank LR, Liu TT. Velocity-selective
arterial spin labeling. Magn Reson Med. 2006;55:1334–41.
98. Qiu D, Straka M, Zun Z, Bammer R, Moseley ME, Zaharchuk G. CBF
measurements using multidelay pseudocontinuous and velocity-selective
arterial spin labeling in patients with long arterial transit delays: Comparison
with xenon CT CBF. J Magn Reson Imaging. 2012;36:110–9.
99. Do Hung, Ramanan V, Jao T, Wright G, Nayak K, Ghugre N. Non-contrast
Myocardial Perfusion Assessment in Porcine Acute Myocardial Infarction
using Arterial Spin Labeled CMR. BioMed Central: In SCMR 19th Scientific
Sessions, Los Angeles; 2016. http://link.springer.com/article/10.1186/1532-
429X-18-S1-O7.
100. Madsen PL, Holm S, Herning M, Lassen NA. Average blood flow and oxygen
uptake in the human brain during resting wakefulness: a critical appraisal of
the Kety-Schmidt technique. J Cereb Blood Flow Metab. 1993;13:646–55.
101. Daley PJ, Sagar KB, Wann LS. Doppler echocardiographic measurement of
flow velocity in the ascending aorta during supine and upright exercise.
Br Heart J. 1985;54:562–7.
102. Naruse M, Inagami T. Markedly elevated specific renin levels in the adrenal
in genetically hypertensive rats. Proc Natl Acad Sci. 1982;79:3295–9.
103. Winter P, Kampf T, Helluy X, Gutjahr FT, Meyer CB, Rommel E, Bauer WR,
Jakob PM, Herold V. Fast retrospectively triggered local pulse-wave velocity
measurements in mice with CMR-microscopy using a radial trajectory.
J Cardiovasc Magn Reson. 2013;15:88.
104. Hiller KH, Waller C, Voll S, Haase A, Ertl G, Bauer WR. Combined high-speed
NMR imaging of perfusion and microscopic coronary conductance vessels
in the isolated rat heart. Microvasc Res. 2001;62:327–34.
Kober et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:22 Page 16 of 16
